Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.360
-0.040 (-2.86%)
At close: Jun 26, 2026
Autolus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | - | -299.42 | -202.07 | -208.38 | -141.98 | -142.1 |
Depreciation & Amortization | - | 10.44 | 7.67 | 6.57 | 7.24 | 8.46 |
Stock-Based Compensation | - | 14.64 | 14.96 | 11.2 | 13.42 | 9.94 |
Other Adjustments | 4.54 | 34.22 | -40.68 | 44.74 | -11.03 | 5.43 |
Change in Receivables | -22.02 | -25.11 | - | - | -6.45 | - |
Changes in Inventories | -22.58 | -36.66 | -11.33 | - | - | - |
Changes in Accounts Payable | 5.78 | 10.61 | 15.52 | -0.51 | 14.91 | -1.82 |
Changes in Accrued Expenses | -6.21 | - | - | 1 | - | -2.02 |
Changes in Unearned Revenue | 2.89 | - | - | - | - | - |
Changes in Other Operating Activities | -14.22 | 169.59 | -370.53 | -0.2 | - | 4.25 |
Operating Cash Flow | -206 | -123.67 | -588.82 | -145.59 | -103.69 | -117.86 |
Capital Expenditures | -14.37 | -19.64 | -21.5 | -10.99 | -10.87 | -8.86 |
Purchases of Intangible Assets | - | -8.16 | -12.63 | - | - | - |
Purchases of Investments | -145.66 | - | - | - | - | - |
Proceeds from Sale of Investments | 395.73 | - | - | - | - | - |
Other Investing Activities | - | 12.14 | 29.27 | - | 0.84 | - |
Investing Cash Flow | 227.61 | -15.65 | -4.85 | -10.99 | -10.04 | -8.86 |
Long-Term Debt Issued | - | - | - | - | 68.74 | 50 |
Long-Term Debt Repaid | - | -3 | -5.43 | - | -3.4 | - |
Net Long-Term Debt Issued (Repaid) | - | -3 | -5.43 | - | 65.34 | 50 |
Issuance of Common Stock | - | - | 548.13 | 0.03 | 161.23 | 246.03 |
Net Common Stock Issued (Repurchased) | - | - | 548.13 | 0.03 | 161.23 | 246.03 |
Other Financing Activities | -2.16 | 4.09 | 43.6 | -0.91 | -10.19 | -11.96 |
Financing Cash Flow | -4.6 | 1.09 | 586.3 | -0.88 | 216.38 | 284.06 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -7.2 | -1.65 | -0.48 | 15.03 | 2.18 | -0.75 |
Net Cash Flow | 20.1 | -138.24 | -7.37 | -142.43 | 102.65 | 156.59 |
Free Cash Flow | -220.37 | -143.31 | -610.31 | -156.57 | -114.57 | -126.72 |
FCF Margin | -237.92% | -190.09% | -6094.14% | -9221.02% | -1796.30% | -8408.63% |
Free Cash Flow Per Share | -0.83 | -0.54 | -2.39 | -0.90 | -1.21 | -1.76 |
Levered Free Cash Flow | -337.68 | -156.18 | -587.67 | -212.51 | -65.36 | -92.09 |
Unlevered Free Cash Flow | -311.89 | -134.33 | -643.71 | -183.85 | -177.61 | -141.8 |